A. Marcellusi, C. Bini, L. Fioravanti, S. Ripoli, and P. Morelli, “Cost-effectiveness of Brentuximab Vedotin plus chemotherapy as frontline treatment of systemic anaplastic large cell lymphoma in Italy”, Grhta, vol. 12, no. 1, pp. 106–117, Apr. 2025.